Caption Management, LLC Pds Biotechnology Corp Call Options Transaction History

Caption Management, LLC

  • $9.79 Billion
  • Q1 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

May 15, 2025
BUY
$1.18 - $1.8 $21,358 - $32,580
18,100 Added 66.06%
45,500 $54,000
Q4 2024

Feb 14, 2025
SELL
$1.63 - $4.11 $118,337 - $298,386
-72,600 Reduced 72.6%
27,400 $44,000
Q3 2024

Nov 14, 2024
SELL
$2.93 - $4.23 $55,670 - $80,370
-19,000 Reduced 15.97%
100,000 $382,000
Q2 2024

Aug 14, 2024
BUY
$2.55 - $4.02 $303,450 - $478,379
119,000 New
119,000 $348,000

Others Institutions Holding PDSB

# of Institutions
55
Shares Held
8.24M
Call Options Held
151K
Put Options Held
1.2K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $39.3M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email